S-Kap Unternehmensbeteiligungs

S-Kap Unternehmensbeteiligungs is a private equity firm based in Pforzheim, Germany, founded in 2000. The firm specializes in providing financing to medium-sized companies and entrepreneurs looking for investment opportunities. By focusing on startups and established businesses, S-Kap aims to support growth and development in various sectors, fostering innovation and financial success in the companies it invests in.

Andrej Baraban

Investment Manager

Sacha Grau

Investment Manager

Florentin Walker

Managing Director

6 past transactions

Gyde

Seed Round in 2022
Gyde is a developer of a digital platform focused on leadership and talent development. The company provides a comprehensive talent development solution that includes digital micro-learning and cross-company coaching for managers. Through its platform, Gyde facilitates app-based microlearning and thematic exercises, allowing employees to engage in peer coaching sessions and group coaching via video calls. This approach fosters social learning by connecting employees with peers from different organizations, addressing various leadership challenges and enhancing their professional growth.

Deep Care

Seed Round in 2022
Operator of a health management platform intended to provide a digital health coach. The company provides a plug-and-play desktop device that records posture using a 3D sensor and recognizes unhealthy behavior using artificial intelligence, enabling people with instructions to exercise, work ergonomically, and improve behavior like drinking water.

BrandMaker

Series C in 2018
BrandMaker GmbH specializes in designing and developing marketing resource management (MRM) and customer engagement software solutions tailored for various industries. The company's offerings encompass project and workflow management, digital asset management, brand management, content marketing, local area marketing, customer engagement, and performance management. Key products include Marketing Planer, Job Manager, Review Manager, Reporting Center, Media Pool, and Sales Enablement Workbench, among others. Founded in 1999 and headquartered in Karlsruhe, Germany, BrandMaker was previously known as pi-consult GmbH until its rebranding in 2009. The company is recognized as a leader in MRM by industry analysts and serves over 300 prominent clients, including Bayer and Daimler, who rely on its solutions to enhance marketing planning and execution across diverse markets in Europe.

BrandMaker

Series B in 2017
BrandMaker GmbH specializes in designing and developing marketing resource management (MRM) and customer engagement software solutions tailored for various industries. The company's offerings encompass project and workflow management, digital asset management, brand management, content marketing, local area marketing, customer engagement, and performance management. Key products include Marketing Planer, Job Manager, Review Manager, Reporting Center, Media Pool, and Sales Enablement Workbench, among others. Founded in 1999 and headquartered in Karlsruhe, Germany, BrandMaker was previously known as pi-consult GmbH until its rebranding in 2009. The company is recognized as a leader in MRM by industry analysts and serves over 300 prominent clients, including Bayer and Daimler, who rely on its solutions to enhance marketing planning and execution across diverse markets in Europe.

Amcure

Series B in 2016
amcure GmbH is a clinical-stage biopharmaceutical company based in Eggenstein-Leopoldshafen, Germany, focused on the research and development of peptide-based compounds designed to treat highly metastatic forms of squamous cancer. Founded in 2011 as a spin-off from the Karlsruhe Institute of Technology, amcure is dedicated to targeting the tumor-specific co-receptor CD44v6, which plays a critical role in activating various receptor tyrosine kinase pathways. Their lead candidate, AM001, effectively inhibits pathways associated with vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), providing a novel therapeutic approach to combat metastatic tumors. The company has advanced its first-in-class CD44v6 inhibitor, AMC303, into clinical development for solid tumors as of late 2016, aiming to improve treatment options for cancers such as pancreatic, head and neck, gastric, colorectal, breast, and lung cancer.

Onventis

Venture Round in 2015
Onventis specializes in developing cloud-based e-procurement solutions focused on supplier relationship management and vendor-managed procurement. The company offers a comprehensive suite of tools designed to enhance purchasing and financial processes. Key products include TradeCore Buyer, an integrated platform for supplier management, sourcing, order management, and analytics; TradeCore Vendor, which supports wholesalers of indirect goods with mobile ordering, approval options, and catalog management; and TradeCore Provider, a solution for group procurement and collaborative commerce. By providing these solutions, Onventis enables clients to optimize and automate procurement activities, improve process efficiency, gain control over financial situations, and achieve cost savings while ensuring compliance with relevant guidelines and regulations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.